Top Ad unit 728 × 90

Radiology News


FDA clears F18-FLT

"FDA approval of a multicenter investigational new drug application has cleared away regulatory obstacles that stood in the way of definitive trials to establish the clinical efficacy of a PET imaging agent that measures cell proliferation in cancerous tumors.Molecular imaging researchers have touted F-18-labeled 3'-deoxy-3'-fluorothymidine (FLT) for the potential complementary role it could play with FDG for cancer imaging. "
Complete article here-
FDA clears F18-FLT Reviewed by Sumer Sethi on Wednesday, February 11, 2009 Rating: 5

No comments:

All Rights Reserved by Sumer's Radiology Blog © 2014 - 2015
Powered By Blogger,

Contact Form


Email *

Message *

All contents copyrights with Sumer Sethi. Powered by Blogger.